Living with Wilson A patient-led project

← Back to all answers

Did Wilson disease cause my irregular periods, and will my cycle improve on treatment?

Yes, copper overload from untreated Wilson disease can disrupt the menstrual cycle; many women see improvement after effective treatment begins, though recovery timelines vary and fertility evaluation may be warranted.

Irregular or absent periods are a recognised but underappreciated presentation of Wilson disease in women, and yes — the copper accumulation is the likely culprit. If your menstrual irregularity predated your diagnosis and no other cause was found, Wilson disease is a plausible explanation. The good news is that for most women, cycles do improve once treatment brings copper under control, though the degree and pace of recovery varies.1

This is one of the many ways Wilson disease is a “great imitator” — symptoms that look like hormonal or gynaecological problems turn out to have a metabolic root.2 Many women with Wilson disease have spent years being investigated for polycystic ovarian syndrome, stress-related cycle changes, or unexplained infertility before the underlying diagnosis was made.

How excess copper disrupts the menstrual cycle

The menstrual cycle is regulated by a finely tuned hormonal axis — the hypothalamus, pituitary, and ovaries working in concert. Copper overload can disrupt this at multiple levels.

The liver plays a central role in metabolising and clearing sex hormones. In Wilson disease, chronic copper accumulation causes progressive hepatocellular damage, and a damaged liver metabolises oestrogens and other reproductive hormones less efficiently.3 The resulting hormonal imbalance can manifest as:

  • Irregular cycle length
  • Prolonged gaps between periods (oligomenorrhoea)
  • Complete absence of periods (secondary amenorrhoea)
  • Heavy or unpredictable bleeding in some cases

Copper also has direct toxic effects on cells beyond the liver. High circulating copper levels have been proposed to affect ovarian function directly, though the evidence here is less established.1

A 2018 case report described a woman in her twenties presenting with amenorrhoea as the primary complaint, with normal urinary copper levels but other biochemical and clinical features consistent with Wilson disease — illustrating that menstrual disruption can be a leading symptom before the classical markers appear.4

What the data shows on reproductive function after treatment

A 2021 prospective study by Iorio and colleagues examined reproductive outcomes in women with Wilson disease who had been on long-term treatment for the hepatic form of the disease.1 The majority of participants had documented menstrual irregularity before treatment began. After a period of sustained copper-lowering therapy, most women had regular cycles and several had conceived successfully. The study concluded that effective treatment of Wilson disease is associated with meaningful improvement in reproductive function.

This mirrors the broader clinical experience documented in pregnancy outcome studies: women with Wilson disease who are well-controlled on treatment have largely normal pregnancy outcomes, while untreated or poorly controlled disease is associated with significantly higher rates of miscarriage, stillbirth, and infertility.56

The implication for you is encouraging: if your copper levels are now being well-managed on medication, your menstrual cycle has a genuine chance of normalising. The timeline, though, is unpredictable — some women see improvement within months; others take longer.

What “normalisation” actually looks like

“Normal cycle” does not mean every 28 days on the dot. It means a cycle that falls within a broadly regular pattern that allows for prediction and planning. For women with Wilson disease, improvement typically means:

  • Cycles returning to a predictable frequency (roughly every 21–35 days)
  • Anovulatory cycles becoming less frequent
  • Hormonal markers (FSH, LH, oestradiol) trending toward normal ranges

This improvement is not guaranteed and does not always happen fully. If your liver damage from before diagnosis was significant, some degree of hepatic dysfunction may persist even with good treatment, and this can continue to affect hormonal metabolism. Similarly, if there was pre-existing gynaecological pathology (such as PCOS) concurrent with Wilson disease, treatment of the Wilson disease will not address the other condition.

When to ask for a referral to a gynaecologist or reproductive specialist

You should raise this with your hepatologist at your next appointment. Specific situations that warrant a gynaecology or fertility referral:

  • Cycles have not improved after 12 months of stable, well-controlled treatment
  • You are trying to conceive and have been unsuccessful after 6 months of regular unprotected intercourse
  • Your AMH (anti-Müllerian hormone) or other ovarian reserve markers are low
  • You have symptoms suggesting another concurrent condition (such as PCOS, thyroid disease, or premature ovarian insufficiency)

Copper management and gynaecological care can proceed in parallel — they are not mutually exclusive, and a reproductive specialist who is aware of your diagnosis can factor it into their assessment.

Implications for contraception and planned pregnancy

If your cycle is still irregular, fertility can be unpredictable — some months you may ovulate when you do not expect to, and others you may not. This matters for contraception planning if pregnancy is not currently desired, and for timing if it is.

Before attempting pregnancy, the AASLD 2022 guidelines recommend ensuring your Wilson disease is well-controlled and your copper parameters are stable.3 Switching medications before conception may be appropriate depending on what you are currently taking — this is discussed in the pregnancy post and the switch from trientine to zinc post.

If you are planning a pregnancy, involving a maternal-fetal medicine specialist alongside your hepatologist early — ideally before conception — gives the best results.5

Gender differences in how Wilson disease presents

It is worth noting that women with Wilson disease more commonly present with hepatic features than with the neurological features more often seen in men — and liver-dominant disease is more likely to affect hormonal function because of direct hepatic copper loading.7 This may partly explain why gynaecological symptoms, including menstrual irregularity, are a more common presenting complaint in women. It is also one reason women sometimes wait longer for a diagnosis: menstrual problems, fatigue, and liver enzyme abnormalities can each be attributed to more common conditions before Wilson disease is considered.

This post is for patient education and does not substitute for individualised medical advice. Please discuss your cycle history and any fertility concerns directly with your hepatologist and, if appropriate, a gynaecologist.

References


  1. Iorio, Giuseppe Gabriele, Alessandro Conforti, Roberta Vallone, Luigi Carbone, and Margherita Matarazzo. “Reproductive Function of Long-term Treated Patients with Hepatic Onset of Wilson’s Disease: A Prospective Study.” Reproductive BioMedicine Online 42 (2021): 835–841. https://doi.org/10.1016/j.rbmo.2020.12.012 

  2. Czlonkowska, Anna, Tomasz Litwin, Piotr Dusek, Per Jenner, Luigi Bertini, Karl Bjorn-Johansson, Roser Lorenzana, and Alistair J. Wilson. “Wilson Disease.” Nature Reviews Disease Primers 4, no. 1 (2018): article 21. https://doi.org/10.1038/s41572-018-0024-5 

  3. Schilsky, Michael L., Eve A. Roberts, Jeff M. Bronstein, Anil Dhawan, James P. Hamilton, Aftab Rivzi, Valentina Medici, et al. “A Multidisciplinary Approach to the Diagnosis and Management of Wilson Disease: 2022 Practice Guidance on Wilson Disease from the American Association for the Study of Liver Diseases.” Hepatology 82, no. 3 (2022): E41–E90. https://doi.org/10.1002/hep.32801 

  4. Mukherjee, Annanya. “Wilson Disease Presenting with Amenorrhea and Normal Urinary Copper Levels.” Journal of Medical Science and Clinical Research 6, no. 9 (2018). https://doi.org/10.18535/jmscr/v6i9.68 

  5. Pfeiffenberger, Jan, Sandra Beinhardt, Daniel N. Gotthardt, Nicola Haag, Clarissa Freissmuth, et al. “Pregnancy in Wilson’s Disease: Management and Outcome.” Hepatology 67, no. 4 (2018): 1261–1269. https://doi.org/10.1002/hep.29490 

  6. Weinstein, David, and Dhiren A. Shah. “Wilson Disease and Pregnancy.” Clinical Liver Disease 23, no. 1 (2024). https://doi.org/10.1097/cld.0000000000000110 

  7. Litwin, T., G. Gromadzka, and A. Czlonkowska. “Gender Differences in Wilson’s Disease.” Journal of the Neurological Sciences 312, no. 1–2 (2012): 31–35. https://doi.org/10.1016/j.jns.2011.08.028 

  8. European Association for the Study of the Liver. “EASL Clinical Practice Guidelines: Wilson’s Disease.” Journal of Hepatology 56, no. 3 (2012): 671–685. https://doi.org/10.1016/j.jhep.2011.11.007 

This is patient education, not medical advice. Always consult your own clinical team about decisions for your care.